HighTower Advisors, LLC - PARATEK PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$117,000
+39.3%
53,000
+60.6%
0.00%
Q1 2023$84,000
+35.5%
33,0000.0%0.00%
Q4 2022$62,000
-27.1%
33,0000.0%0.00%
Q3 2022$85,000
+32.8%
33,0000.0%0.00%
Q2 2022$64,000
-11.1%
33,000
+34.7%
0.00%
Q1 2022$72,000
-34.5%
24,5000.0%0.00%
Q4 2021$110,000
-7.6%
24,5000.0%0.00%
Q3 2021$119,000
-28.7%
24,5000.0%0.00%
Q2 2021$167,000
+51.8%
24,500
+58.1%
0.00%
Q1 2021$110,000
+13.4%
15,5000.0%0.00%
Q4 2020$97,000
+15.5%
15,500
-0.3%
0.00%
Q3 2020$84,000
+3.7%
15,5430.0%0.00%
Q2 2020$81,000
+65.3%
15,5430.0%0.00%
Q1 2020$49,00015,5430.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders